UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Nelfinavir and lenalidomide/dexamethasone in patients with lenalidomide-refractory multiple myeloma. A phase I/II Trial (SAKK 39/10)

Blood cancer journal (New York), 2019-08, Vol.9 (9), p.70-8, Article 70

2019

Volltextzugriff (PDF)

Rituximab, bendamustine, and lenalidomide in patients with aggressive B cell lymphoma not eligible for high-dose chemotherapy or anthracycline-based therapy: phase I results of the SAKK 38/08 trial

Annals of hematology, 2013-08, Vol.92 (8), p.1033-1040

2013

Volltextzugriff (PDF)

2500 Orteronel (Ort) maintenance therapy in patients (pts) with metastatic castration resistant prostate cancer (mCRPC) and non-progressive disease after first-line docetaxel (Doc) therapy: Results of a multicenter randomized double-blind placebo-controlled phase III trial (SAKK 08/11)

European journal of cancer (1990), 2015-09, Vol.51, p.S473-S473

2015

Volltextzugriff (PDF)

1943 Adjuvant treatment recommendations for ER+ early breast cancer patients by Swiss tumor boards (SAKK 26/10)

European journal of cancer (1990), 2015-09, Vol.51, p.S313-S313

2015

Volltextzugriff (PDF)

Preliminary results from SIESTA, a pilot observational study investigating sleep quality in prostate cancer patients

European urology open science (Online), 2022-11, Vol.45, p.S118

2022

Volltextzugriff (PDF)

Preoperative chemotherapy and radiotherapy concomitant to cetuximab in stage IIIB NSCLC: A multicenter phase II SAKK

Annals of oncology, 2017-09, Vol.28, p.v457-v457

2017

Volltextzugriff (PDF)

Results of the phase-I open-label clinical trial SAKK 06/14 assessing safety of intravesical instillation of the recombinant BCG VPM1002BC in patients with non-muscle invasive bladder cancer and previous failure to conventional BCG therapy

European urology supplements : official journal of the European Association of Urology, 2018-03, Vol.17 (2), p.e1050

2018

Volltextzugriff (PDF)

728 - Results of the phase-I open-label clinical trial SAKK 06/14 assessing safety of intravesical instillation of the recombinant BCG VPM1002BC in patients with non-muscle invasive bladder cancer and previous failure to conventional BCG therapy

European urology supplements : official journal of the European Association of Urology, 2018-03, Vol.17 (2), p.e1050-e1050

2018

Volltextzugriff (PDF)

Treatment of chronic hepatitis C genotype 1 with triple therapy comprising telaprevir or boceprevir

Swiss medical weekly, 2012, Vol.142, p.w13516

2012

Volltextzugriff (PDF)

An in vivo study of a growth-factor enhanced, cell free, two-layered collagen–tricalcium phosphate in deep osteochondral defects

Biomaterials, 2006-06, Vol.27 (18), p.3387-3395

2006

Volltextzugriff (PDF)

Rituximab, bendamustine and lenalidomide in patients with aggressive B‐cell lymphoma not eligible for anthracycline‐based therapy or intensive salvage chemotherapy – SAKK 38/08

British journal of haematology, 2016-07, Vol.174 (2), p.255-263

2016

Volltextzugriff (PDF)

The active involvement of patients in oncology research

Cancer treatment reviews, 2024-11, Vol.130, p.102822, Article 102822

2024

Volltextzugriff (PDF)

Assessment of minor health disorders with decision tree-based triage in community pharmacies

Research in social and administrative pharmacy, 2022-05, Vol.18 (5), p.2867-2873

2022

Volltextzugriff (PDF)

Adjuvant treatment recommendations for patients with ER-positive/HER2-negative early breast cancer by Swiss tumor boards using the 21-gene recurrence score (SAKK 26/10)

BMC cancer, 2017-04, Vol.17 (1), p.265-265, Article 265

2017

Volltextzugriff (PDF)

Complete subchondral bone defect regeneration with a tricalcium phosphate collagen implant and osteoinductive growth factors: A randomized controlled study in Göttingen minipigs

Journal of biomedical materials research. Part B, Applied biomaterials, 2014-07, Vol.102 (5), p.933-942

2014

Volltextzugriff (PDF)

Y 90 -Ibritumomab tiuxetan (Y 90 -IT) and high-dose melphalan as conditioning regimen before autologous stem cell transplantation for elderly patients with lymphoma in relapse or resistant to chemotherapy: a feasibility trial (SAKK 37/05)

Hematological oncology, 2017-12, Vol.35 (4), p.576-583

2017

Volltextzugriff (PDF)

Orteronel Switch Maintenance Therapy in Metastatic Castration Resistant Prostate Cancer After First-Line Docetaxel: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial (SAKK 08/11)

The Prostate, 2016-12, Vol.76 (16), p.1519-1527

2016

Volltextzugriff (PDF)

Y90‐Ibritumomab tiuxetan (Y90‐IT) and high‐dose melphalan as conditioning regimen before autologous stem cell transplantation for elderly patients with lymphoma in relapse or resistant to chemotherapy: a feasibility trial (SAKK 37/05)

Hematological oncology, 2017-12, Vol.35 (4), p.576-583

2017

Volltextzugriff (PDF)

Complete subchondral bone defect regeneration with a tricalcium phosphate collagen implant and osteoinductive growth factors: A randomized controlled study in Göttingen minipigs

Journal of biomedical materials research. Part B, Applied biomaterials, 2014-07, Vol.102 (5), p.933-942

2014

Volltextzugriff (PDF)

No effect of subperiosteal growth factor application on periosteal neo-chondrogenesis in osteoperiosteal bone grafts for osteochondral defect repair

International orthopaedics, 2013-06, Vol.37 (6), p.1171-1178

2013

Volltextzugriff (PDF)

Molecular characterization of spontaneous and growth-factor-augmented chondrogenesis in periosteum-bone tissue transferred into a joint

Histochemistry and cell biology, 2005-06, Vol.123 (4-5), p.447-456

2005

Volltextzugriff (PDF)

Functional Properties of Recombinant Calpain I and of Mutants Lacking Domains III and IV of the Catalytic Subunit

The Journal of biological chemistry, 1997-10, Vol.272 (41), p.25802-25808

1997

Volltextzugriff (PDF)

Alternative messenger RNA splicing and enzyme forms of cathepsin B in human osteoarthritic cartilage and cultured chondrocytes

Arthritis and rheumatism, 2001-08, Vol.44 (8), p.1819-1831

2001

Volltextzugriff (PDF)

1 – 25 von 25

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(22)
Mit Volltextzugriff
(24)

Publikationsform

Artikel
(25)

Sprache

Englisch
(25)

Erscheinungsjahr

n.n

Thema

Science & Technology
(15)
Life Sciences & Biomedicine
(13)
Humans
(11)
Aged
(8)
Female
(7)
Male
(7)
Treatment Outcome
(7)
Aged, 80 And Over
(6)
Animals
(5)
Middle Aged
(5)
Oncology
(5)
Adult
(4)
Hematology
(4)
Swine
(4)
Swine, Miniature
(4)
Antineoplastic Combined Chemotherapy Protocols - Adverse Effects
(3)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(3)
Growth Factors
(3)
Osteochondral Defect
(3)
Technology
(3)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Nelfinavir and lenalidomide/dexamethasone in patients with lenalidomide-refractory multiple myeloma. A phase I/II Trial (SAKK 39/10)

Rituximab, bendamustine, and lenalidomide in patients with aggressive B cell lymphoma not eligible for high-dose chemotherapy or anthracycline-based therapy: phase I results of the SAKK 38/08 trial

2500 Orteronel (Ort) maintenance therapy in patients (pts) with metastatic castration resistant prostate cancer (mCRPC) and non-progressive disease after first-line docetaxel (Doc) therapy: Results of a multicenter randomized double-blind placebo-controlled phase III trial (SAKK 08/11)

1943 Adjuvant treatment recommendations for ER+ early breast cancer patients by Swiss tumor boards (SAKK 26/10)

Preliminary results from SIESTA, a pilot observational study investigating sleep quality in prostate cancer patients

Preoperative chemotherapy and radiotherapy concomitant to cetuximab in stage IIIB NSCLC: A multicenter phase II SAKK

Results of the phase-I open-label clinical trial SAKK 06/14 assessing safety of intravesical instillation of the recombinant BCG VPM1002BC in patients with non-muscle invasive bladder cancer and previous failure to conventional BCG therapy

728 - Results of the phase-I open-label clinical trial SAKK 06/14 assessing safety of intravesical instillation of the recombinant BCG VPM1002BC in patients with non-muscle invasive bladder cancer and previous failure to conventional BCG therapy

Treatment of chronic hepatitis C genotype 1 with triple therapy comprising telaprevir or boceprevir

An in vivo study of a growth-factor enhanced, cell free, two-layered collagen–tricalcium phosphate in deep osteochondral defects

Rituximab, bendamustine and lenalidomide in patients with aggressive B‐cell lymphoma not eligible for anthracycline‐based therapy or intensive salvage chemotherapy – SAKK 38/08

The active involvement of patients in oncology research

Assessment of minor health disorders with decision tree-based triage in community pharmacies

Adjuvant treatment recommendations for patients with ER-positive/HER2-negative early breast cancer by Swiss tumor boards using the 21-gene recurrence score (SAKK 26/10)

Complete subchondral bone defect regeneration with a tricalcium phosphate collagen implant and osteoinductive growth factors: A randomized controlled study in Göttingen minipigs

Y 90 -Ibritumomab tiuxetan (Y 90 -IT) and high-dose melphalan as conditioning regimen before autologous stem cell transplantation for elderly patients with lymphoma in relapse or resistant to chemotherapy: a feasibility trial (SAKK 37/05)

Orteronel Switch Maintenance Therapy in Metastatic Castration Resistant Prostate Cancer After First-Line Docetaxel: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial (SAKK 08/11)

Activity of Lutetium-177 Prostate-specific Membrane Antigen and Determinants of Outcomes in Patients with Metastatic Castration-resistant Prostate Cancer Previously Treated with Cabazitaxel: The PACAP Study

Orteronel Switch Maintenance Therapy in Metastatic Castration Resistant Prostate Cancer After First-Line Docetaxel: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial (SAKK 08/11): Orteronel Maintenance in mCRPC After First-Line Docetaxel

Y90‐Ibritumomab tiuxetan (Y90‐IT) and high‐dose melphalan as conditioning regimen before autologous stem cell transplantation for elderly patients with lymphoma in relapse or resistant to chemotherapy: a feasibility trial (SAKK 37/05)

Complete subchondral bone defect regeneration with a tricalcium phosphate collagen implant and osteoinductive growth factors: A randomized controlled study in Göttingen minipigs

No effect of subperiosteal growth factor application on periosteal neo-chondrogenesis in osteoperiosteal bone grafts for osteochondral defect repair

Molecular characterization of spontaneous and growth-factor-augmented chondrogenesis in periosteum-bone tissue transferred into a joint

Functional Properties of Recombinant Calpain I and of Mutants Lacking Domains III and IV of the Catalytic Subunit

Alternative messenger RNA splicing and enzyme forms of cathepsin B in human osteoarthritic cartilage and cultured chondrocytes

Suchergebnisse filtern